DLK Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.82M Sell
48,481
-7,302
-13% -$589K 1.62% 25
2026
Q1
$4.83M Buy
55,783
+108
+0.2% +$10.3K 1.91% 27
2025
Q4
$5.35M Buy
55,675
+3,161
+6% +$307K 1.99% 21
2025
Q3
$5M Buy
52,514
+43
+0.1% +$3.95K 1.88% 22
2025
Q2
$4.57M Buy
52,471
+891
+2% +$75.6K 1.73% 29
2025
Q1
$4.64M Buy
51,580
+3,947
+8% +$353K 1.94% 24
2024
Q4
$3.8M Sell
47,633
-2,270
-5% -$197K 1.59% 28
2024
Q3
$4.49M Buy
49,903
+1,422
+3% +$120K 1.72% 27
2024
Q2
$3.82M Buy
48,481
+1,363
+3% +$112K 1.58% 26
2024
Q1
$4.11M Buy
47,118
+9,258
+24% +$790K 1.75% 26
2023
Q4
$3.12M Buy
+37,860
New +$2.89M 1.42% 30

Other funds holding MDT

DLK Investment Management's MDT Position: Q2 2026 in Review

DLK Investment Management reduced its Medtronic (MDT) stake by 13% in Q2 2026, selling an estimated $589K and leaving 48,481 shares worth $3.82M. The position accounts for 1.62% of the portfolio, ranked #25.

DLK Investment Management first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.35M in Q4 2025. 545 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • DLK Investment Management held 48,481 shares of Medtronic worth $3.82M as of Q2 2026.
  • DLK Investment Management sold 7,302 Medtronic shares in Q2 2026, an estimated $589K.
  • Medtronic made up 1.62% of DLK Investment Management's portfolio in Q2 2026, its #25 holding.
  • DLK Investment Management first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • DLK Investment Management's Medtronic position peaked at $5.35M in Q4 2025.
  • 545 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on DLK Investment Management's 13F filing for Q2 2026, filed 14 Jul 2026.